艾伯维Abbvie Inc (ABBV) 2023年10-K年度报告「NYSE」.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-K(MARK ONE)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGEACT OF 1934For the fiscal year ended December 31,2023OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934F

2、or the transi?on period from to Commission file number 001-35565AbbVie Inc.(Exact name of registrant as specified in its charter)Delaware 32-0375147(State or other jurisdic?on ofincorpora?on or organiza?on)(I.R.S.employeriden?fica?on number)1 North Waukegan RoadNorth Chicago,Illinois 60064-6400(847)

3、932-7900(Address,including zip code,and telephone number of principal execu?ve offices)Securi?es Registered Pursuant to Sec?on 12(b)of the Act:Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which RegisteredCommon Stock,par value$0.01 per shareABBV New York Stock ExchangeChicago Stock E

4、xchange1.375%Senior Notes due 2024ABBV24New York Stock Exchange1.250%Senior Notes due 2024ABBV24BNew York Stock Exchange0.750%Senior Notes due 2027ABBV27New York Stock Exchange2.125%Senior Notes due 2028ABBV28New York Stock Exchange2.625%Senior Notes due 2028ABBV28BNew York Stock Exchange2.125%Senio

5、r Notes due 2029ABBV29New York Stock Exchange1.250%Senior Notes due 2031ABBV31New York Stock ExchangeIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securi?es Act.Yes No Indicate by check mark if the registrant is not required to file reports pu

6、rsuant to Sec?on 13 or 15(d)of the Act.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Sec?on 13 or 15(d)of theSecuri?es Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to filesuch re